REG - Conygar Investmnt Co - ZDP Share Acquisition Programme

Conygar Investment CoAnnouncement

22/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260122:nRSV8629Pa&default-theme=true

RNS Number : 8629P  Conygar Investment Company PLC(The)  22 January 2026

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, TO ANY US PERSONS OR INTO THE UNITED STATES, AUSTRALIA, CANADA,
SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE
DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH
JURISDICTION.

 

22 January 2026

 

THE CONYGAR INVESTMENT COMPANY PLC (THE "COMPANY")

 

CONYGAR ZDP PLC (THE "ISSUER")

 

ZDP Share Acquisition programme

The Conygar Investment Company PLC announces the commencement of a share
acquisition programme (the "Programme") of the zero dividend preference shares
("ZDP Shares") in the capital of the Issuer currently admitted to the Official
List of the International Stock Exchange.

The Company has appointed Panmure Liberum Limited as its broker and Liberum
Wealth Limited as its agent to purchase ZDP Shares, up to a maximum aggregate
consideration of £2,500,000. ZDP Shares will be acquired at a share price up
to the Accrued Capital Entitlement of each ZDP Share on the date of the
transaction.

The Programme will be funded by the Company's cash reserves. It is anticipated
that any ZDP Shares purchased within the Programme will remain held by the
Company until the ZDP Repayment Date.

Any purchase of the ZDP Shares contemplated by this announcement will be
carried out outside of a regulated market or multilateral trading facility.

The Company has authorised the Programme to commence from today and continue
until 3 March 2026.

Details of purchases of any ZDP Shares made by the Company will be notified to
a Regulatory Information Service by the Company following any acquisition as
required by the Market Abuse Regulation.

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

Capitalised terms used but not defined in this announcement have the meaning
given to them in the listing document published by the Issuer on 3 October
2023.

Enquiries:

 

The Conygar Investment Company PLC

Robert Ware / David Baldwin: 020 7258 8670

 

Panmure Liberum (Nominated Adviser and Broker)

Chris Clarke / Jamie Richards: 020 3100 2185

 

Temple Bar Advisory (Public Relations)

Alex Child-Villiers: 07795 425580

Sam Livingstone: 07769 655437

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUASRRNOUAUUR



            Copyright 2019 Regulatory News Service, all rights reserved